KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes
Authors:
Open Access
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 115, 108924
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (81602226)
- China Postdoctoral Science Foundation funded project (2016M590641)
- Provincial Project of Medical and Technology Development Program of Shandong (2014WS0091)
- Provincial Natural Science Foundation of Shandong (ZR2015HQ002)
This publication has 59 references indexed in Scilit:
- Precision medicine and bladder cancer heterogeneityBulletin du Cancer, 2018
- Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancerBiochemical and Biophysical Research Communications, 2018
- KMT2D Mutation Is Associated With Poor Prognosis in Non–Small-Cell Lung CancerClinical Lung Cancer, 2018
- High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2018
- Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated geneGenes, Chromosomes and Cancer, 2015
- The cancer COMPASS: navigating the functions of MLL complexes in cancerCancer Genetics, 2015
- PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumorsMolecular Carcinogenesis, 2013
- TSC1 involvement in bladder cancer: diverse effects and therapeutic implicationsThe Journal of Pathology, 2013
- CDKN2A homozygous deletion is associated with muscle invasion in FGFR3 ‐mutated urothelial bladder carcinomaThe Journal of Pathology, 2012
- Role for Dpy-30 in ES Cell-Fate Specification by Regulation of H3K4 Methylation within Bivalent DomainsCell, 2011